{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:27:35Z","timestamp":1777894055179,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sanidad de Castilla y Le\u00f3n","award":["GRS 2183\/A\/20"],"award-info":[{"award-number":["GRS 2183\/A\/20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic graft versus host disease (cGVHD) simulating eosinophilic fasciitis (EF) is an underdiagnosed and challenging complication due to the lack of knowledge about its pathogenesis, refractoriness to traditional immunosuppressive agents and their negative impact on the physical function and quality of life. The aim of this study is to describe the clinical-biological characteristics and response to treatment of a case series and to provide a comprehensive literature review on cGVHD related EF involvement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Prospective observational study to describe the clinical and diagnostic evaluation characteristics of patients with EF-like follow-up as part of our multidisciplinary cGVHD consultations. In addition, the literature on joint and\/or fascial musculoskeletal manifestations due to cGVHD was comprehensively reviewed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>118 patients were evaluated in multidisciplinary cGVHD consultations, 39 of whom (33%) developed fasciitis. Notably, 11 patients had isolated joint contractures without sclerotic skin. After a median of three lines of treatment, the vast majority of patients achieved some degree of response. 94 potentially eligible articles were identified by the search strategy, with 17 of them, the majority isolated case reports, making the final selection. The validated staging scales used for the assessment were the Joint and Fascial Score and the Photographic Range of Motion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Fascial\/articular involvement needs to be recognized and evaluated early. To our knowledge, our cohort is the second largest series to have been reported. Literature addressing fascial\/joints complications related to cGVHD is scarce. The search for new biomarkers, the use of advanced imaging techniques and multidisciplinary approach may help improve the prognosis of patients with cGVHD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-022-00262-3","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T09:03:57Z","timestamp":1661245437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review"],"prefix":"10.1186","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5505-7539","authenticated-orcid":false,"given":"Cristina","family":"Hidalgo Calleja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mart\u00edn Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Rom\u00e1n Curto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"V\u00e1zquez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefan\u00eda","family":"P\u00e9rez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Cabrero Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana \u00c1frica","family":"Mart\u00edn L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Caballero Barrig\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Lopez-Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"issue":"10","key":"262_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.bbmt.2017.06.011","volume":"23","author":"S Kurosawa","year":"2017","unstructured":"Kurosawa S, Oshima K, Yamaguchi T, et al. Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease. Biol Blood Marrow Transpl. 2017;23(10):1749\u201358. https:\/\/doi.org\/10.1016\/j.bbmt.2017.06.011.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"9674","key":"262_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JL Ferrara","year":"2009","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(09)60237-3.","journal-title":"Lancet"},{"issue":"19","key":"262_CR3","doi-asserted-by":"publisher","first-page":"30676","DOI":"10.1016\/j.bbmt.2019.10.019","volume":"S1083\u2013S8791","author":"BK Hamilton","year":"2019","unstructured":"Hamilton BK, Storer BE, Wood WA, et al. Disability related to chronic graft-versus-host disease. Biol Blood Marrow Transpl. 2019;S1083\u2013S8791(19):30676\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2019.10.019.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"262_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.apmr.2018.04.034","volume":"100","author":"C Andrews","year":"2019","unstructured":"Andrews C, Smith S, Kennel M, Schilling S, Kalpakjian C. The association of performance status and disease severity in patients with chronic graft-vs-host disease. Arch Phys Med Rehabil. 2019;100(4):606\u201312. https:\/\/doi.org\/10.1016\/j.apmr.2018.04.034.","journal-title":"Arch Phys Med Rehabil"},{"issue":"26","key":"262_CR5","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1056\/nejmra1703472","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med. 2017;377(26):2565\u201379. https:\/\/doi.org\/10.1056\/nejmra1703472.","journal-title":"N Engl J Med"},{"issue":"4","key":"262_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers MED. Chronic graft-versus-host disease. Biol Blood Marrow Transpl. 2003;9(4):215\u201333. https:\/\/doi.org\/10.1053\/bbmt.2003.50026.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"2","key":"262_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","volume":"21","author":"S Arai","year":"2015","unstructured":"Arai S, Arora M, Wang T, et al. Increasing Incidence of chronic graft-versus-host disease inallogeneic transplantation: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transpl. 2015;21(2):266\u201374. https:\/\/doi.org\/10.1016\/j.bbmt.2014.10.021.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"262_CR8","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.bbmt.2016.06.020","volume":"22","author":"M Grube","year":"2016","unstructured":"Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D. Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation\u2014results from a single-center observational study. Biol Blood Marrow Transpl. 2016;22(10):1781\u201391. https:\/\/doi.org\/10.1016\/j.bbmt.2016.06.020.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"262_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","volume":"129","author":"SJ Lee","year":"2017","unstructured":"Lee SJ. Classification systems for chronic graft-versus-host disease. Blood. 2017;129(1):30\u20137. https:\/\/doi.org\/10.1182\/blood-2016-07-686642.","journal-title":"Blood"},{"issue":"10","key":"262_CR10","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1182\/blood-2011-04-314815","volume":"118","author":"PA Carpenter","year":"2011","unstructured":"Carpenter PA. How I conduct a comprehensive chronic graft-versus-host disease assessment. Blood. 2011;118(10):2679\u201387. https:\/\/doi.org\/10.1182\/blood-2011-04-314815.","journal-title":"Blood"},{"issue":"12","key":"262_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11(12):945\u201356. https:\/\/doi.org\/10.1016\/j.bbmt.2005.09.004.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"262_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transpl. 2015;21(3):389\u2013401. https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.001.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"262_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","volume":"27","author":"D Wolff","year":"2021","unstructured":"Wolff D, Radojcic V, Lafyatis R, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report. Transpl Cell Ther. 2021;27(10):817\u201335. https:\/\/doi.org\/10.1016\/j.jtct.2021.06.001.","journal-title":"Transpl Cell Ther"},{"issue":"6","key":"262_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jtct.2021.02.035","volume":"27","author":"KM Williams","year":"2021","unstructured":"Williams KM, Inamoto Y, Im A, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2020 etiology and prevention working group report. Transplant Cell Ther. 2021;27(6):452\u201366. https:\/\/doi.org\/10.1016\/j.jtct.2021.02.035.","journal-title":"Transplant Cell Ther."},{"key":"262_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.09.007","author":"JS Gandelman","year":"2018","unstructured":"Gandelman JS, Zic J, Dewan AK, et al. The anatomic distribution of skin involvement in patients with incident chronic graft versus host disease. Biol Blood Marrow Transpl. 2018. https:\/\/doi.org\/10.1016\/j.bbmt.2018.09.007.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"262_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00520-009-0602-x","volume":"17","author":"I-S Choi","year":"2009","unstructured":"Choi I-S, Jang I-S, Han J-Y, Kim J-H, Lee S-G. Therapeutic experience on multiple contractures in sclerodermoid chronic graft versus host disease. Support Care Cancer. 2009;17(7):851\u20135. https:\/\/doi.org\/10.1007\/s00520-009-0602-x.","journal-title":"Support Care Cancer"},{"issue":"3","key":"262_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.5535\/arm.2019.43.3.347","volume":"43","author":"M Jung","year":"2019","unstructured":"Jung M, Sung IY, Ko EJ. Rehabilitation in children with sclerodermoid chronic graft-versus-host disease: case series. Ann Rehabil Med. 2019;43(3):347\u201351. https:\/\/doi.org\/10.5535\/arm.2019.43.3.347.","journal-title":"Ann Rehabil Med"},{"issue":"11","key":"262_CR18","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1182\/blood-2016-05-715342","volume":"128","author":"Y Inamoto","year":"2016","unstructured":"Inamoto Y, Martin PJ, Flowers MED, et al. Genetic risk factors for sclerotic graft-versus-host disease. Blood. 2016;128(11):1516\u201324. https:\/\/doi.org\/10.1182\/blood-2016-05-715342.","journal-title":"Blood"},{"issue":"25","key":"262_CR19","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","volume":"121","author":"Y Inamoto","year":"2013","unstructured":"Inamoto Y, Storer BE, Petersdorf EW, et al. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood. 2013;121(25):5098\u2013103. https:\/\/doi.org\/10.1182\/blood-2012-10-464198.","journal-title":"Blood"},{"issue":"3","key":"262_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3325\/cmj.2016.57.266","volume":"57","author":"T Vuki\u0107","year":"2016","unstructured":"Vuki\u0107 T, Smith SR, Kele\u010di\u0107 DL, et al. Joint and fascial chronic graftvs- host disease: correlations with clinical and laboratory parameters. Croat Med J. 2016;57(3):266\u201375. https:\/\/doi.org\/10.3325\/cmj.2016.57.266.","journal-title":"Croat Med J"},{"key":"262_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.19271\/IRONS-00054-2018-23","volume":"22","author":"Z Orzechowska","year":"2018","unstructured":"Orzechowska Z, Strojny M, Komisarek O, Krasuska-S\u0142awi\u0144ska E, Paw\u0142owska J. Joint and fascia manifestations in the course of graft-versus-host disease (GVHD) as a diagnostic trail for doctors of various specialties\u2014case report. Issue Rehabil Orthop Neurophysiol Sport Promot. 2018;22:55\u201362. https:\/\/doi.org\/10.19271\/IRONS-00054-2018-23.","journal-title":"Issue Rehabil Orthop Neurophysiol Sport Promot."},{"issue":"4","key":"262_CR22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.38293","volume":"66","author":"Y Inamoto","year":"2014","unstructured":"Inamoto Y, Pidala J, Chai X, et al. Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis Rheumatol (Hoboken, NJ). 2014;66(4):1044\u201352. https:\/\/doi.org\/10.1002\/art.38293.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"4","key":"262_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/bmt.2013.225","volume":"49","author":"Y Inamoto","year":"2014","unstructured":"Inamoto Y, Jagasia M, Wood WA, et al. Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. Bone Marrow Transpl. 2014;49(4):532\u20138. https:\/\/doi.org\/10.1038\/bmt.2013.225.","journal-title":"Bone Marrow Transpl"},{"key":"262_CR24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-785899","author":"S Sarantopoulos","year":"2019","unstructured":"Sarantopoulos S, Cardones AR, Sullivan KM. How I treat refractory chronic graft-versus-host disease. Blood. 2019. https:\/\/doi.org\/10.1182\/blood-2018-04-785899.","journal-title":"Blood"},{"issue":"6","key":"262_CR25","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","volume":"21","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Wolff D, Kitko C, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in chronic graft-versus-host disease: IV. The 2014 response criteria working group report. Biol Blood Marrow Transpl. 2015;21(6):984\u201399. https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.025.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"262_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/bloodadvances.2019000918","volume":"4","author":"Y Inamoto","year":"2020","unstructured":"Inamoto Y, Lee SJ, Onstad LE, et al. Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia. Blood Adv. 2020;4(1):40\u20136. https:\/\/doi.org\/10.1182\/bloodadvances.2019000918.","journal-title":"Blood Adv"},{"issue":"1","key":"262_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13256-021-02735-3","volume":"15","author":"T Chalopin","year":"2021","unstructured":"Chalopin T, Vallet N, Morel M, et al. Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report. J Med Case Rep. 2021;15(1):1\u20135. https:\/\/doi.org\/10.1186\/s13256-021-02735-3.","journal-title":"J Med Case Rep"},{"issue":"2","key":"262_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/RHU.0000000000000212","volume":"21","author":"CC Ganta","year":"2015","unstructured":"Ganta CC, Chatterjee S, Pohlman B, Hojjati M. Chronic graft-versus-host disease presenting as eosinophilic fasciitis: therapeutic challenges and an additional case. J Clin Rheumatol. 2015;21(2):86\u201394. https:\/\/doi.org\/10.1097\/RHU.0000000000000212.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"262_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2340\/00015555-1669","volume":"94","author":"G-Y Chu","year":"2014","unstructured":"Chu G-Y, Lin H-L, Chen G-S, Wu C-Y. Eosinophilic fasciitis following allogeneic bone marrow transplantation in a patient with acute myeloid leukaemia. Acta Derm Venereol. 2014;94(2):221\u20132. https:\/\/doi.org\/10.2340\/00015555-1669.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"262_CR30","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jaad.2008.08.023","volume":"59","author":"AR Patel","year":"2008","unstructured":"Patel AR, Avila D, Malech HL, Pavletic SZ, Yao L, Cowen EW. Rippled skin, fasciitis, and joint contractures. J Am Acad Dermatol. 2008;59(6):1070\u20134. https:\/\/doi.org\/10.1016\/j.jaad.2008.08.023.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"262_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.bmt.1704436","volume":"33","author":"P Sbano","year":"2004","unstructured":"Sbano P, Rubegni P, De Aloe GB, Guidi S, Fimiani M. Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease [2]. Bone Marrow Transpl. 2004;33(8):869\u201370. https:\/\/doi.org\/10.1038\/sj.bmt.1704436.","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"262_CR32","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/10428190410001683787","volume":"45","author":"C Ustun","year":"2004","unstructured":"Ustun C, Ho G. Eosinophilic fasciitis after allogeneic stem cell transplantation: a case report and review of the literature. Leuk Lymphoma. 2004;45(8):1707\u20139. https:\/\/doi.org\/10.1080\/10428190410001683787.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"262_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.RHU.0000037772.99917.86","volume":"9","author":"KW Kim","year":"2003","unstructured":"Kim KW, Yoon CH, Kay CS, Kim HJ, Lee EH, Park SY. Fasciitis after allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. J Clin Rheumatol. 2003;9(1):33\u20136. https:\/\/doi.org\/10.1097\/01.RHU.0000037772.99917.86.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"262_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0002-9343(87)90509-2","volume":"83","author":"V Van Den Bergh","year":"1987","unstructured":"Van Den Bergh V, Tricot G, Fonteyn G, Dom R, Bulcke J. Diffuse fasciitis after bone marrow transplantation. Am J Med. 1987;83(1):139\u201343. https:\/\/doi.org\/10.1016\/0002-9343(87)90509-2.","journal-title":"Am J Med"},{"issue":"5","key":"262_CR35","first-page":"692","volume":"17","author":"HM Markusse","year":"1990","unstructured":"Markusse HM, Dijkmans BA, Fibbe WE. Eosinophilic dasciitis after allogeneic bone marrow transplantation. J Rheumatol. 1990;17(5):692\u20134.","journal-title":"J Rheumatol"},{"issue":"2","key":"262_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/bmt.2008.297","volume":"43","author":"K Oda","year":"2009","unstructured":"Oda K, Nakaseko C, Ozawa S, et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transpl. 2009;43(2):159\u201367. https:\/\/doi.org\/10.1038\/bmt.2008.297.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"262_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jaad.2005.06.015","volume":"53","author":"JV Schaffer","year":"2005","unstructured":"Schaffer JV, McNiff JM, Seropian S, Cooper DL, Bolognia JL. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol. 2005;53(4):591\u2013601. https:\/\/doi.org\/10.1016\/j.jaad.2005.06.015.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"262_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.7326\/0003-4819-120-12-199406150-00004","volume":"120","author":"A Janin","year":"1994","unstructured":"Janin A, Socie G, Devergie A, et al. Fasciitis in chronic graft-versus-host disease: a clinicopathologic study of 14 cases. Ann Intern Med. 1994;120(12):993\u20138. https:\/\/doi.org\/10.7326\/0003-4819-120-12-199406150-00004.","journal-title":"Ann Intern Med"},{"key":"262_CR39","first-page":"70","volume":"88","author":"LE Shulman","year":"1975","unstructured":"Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Phys. 1975;88:70\u201386.","journal-title":"Trans Assoc Am Phys"},{"issue":"2","key":"262_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1699-258X(05)72723-6","volume":"1","author":"A Garc\u00eda-L\u00f3pez","year":"2005","unstructured":"Garc\u00eda-L\u00f3pez A, Fern\u00e1ndez-Delgado C, Hern\u00e1ndez-S\u00e1nchez R, Uceda J, Parody R. Manifestaciones osteomusculares en pacientes sometidos a trasplante alog\u00e9nico de progenitores hematopoy\u00e9ticos. Reumatol Clin. 2005;1(2):112\u20135. https:\/\/doi.org\/10.1016\/S1699-258X(05)72723-6.","journal-title":"Reumatol Clin"},{"issue":"9","key":"262_CR41","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1002\/art.38697","volume":"66","author":"Z Kuzmina","year":"2014","unstructured":"Kuzmina Z, Joe GO, Baird K, et al. Prevalence of isolated joint involvement in chronic graft-versus-host disease Comment on the article by Inamoto et al. Arthritis Rheumatol. 2014;66(9):2646\u20138. https:\/\/doi.org\/10.1002\/art.38697.","journal-title":"Arthritis Rheumatol"},{"issue":"15","key":"262_CR42","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","volume":"118","author":"KJ Martires","year":"2011","unstructured":"Martires KJ, Baird K, Steinberg SM, et al. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood. 2011;118(15):4250\u20137. https:\/\/doi.org\/10.1182\/blood-2011-04-350249.","journal-title":"Blood"},{"issue":"22","key":"262_CR43","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1200\/JCO.2015.65.9615","volume":"34","author":"J Yu","year":"2016","unstructured":"Yu J, Storer BE, Kushekhar K, et al. Biomarker panel for chronic graft-versus-host disease. J Clin Oncol. 2016;34(22):2583\u201390. https:\/\/doi.org\/10.1200\/JCO.2015.65.9615.","journal-title":"J Clin Oncol"},{"issue":"4","key":"262_CR44","first-page":"255","volume":"28","author":"A Pola\u0144ska","year":"2011","unstructured":"Pola\u0144ska A, Da\u0144czak-Pazdrowska A, Silny W, Sadowska A, Jenerowicz D, Osmola-Ma\u0144kowska A, Olek-Hrab K. High-frequency ultrasonography in monitoring the effects of treatment of selected dermatoses. Postep Dermatologii i Alergol. 2011;28(4):255\u201360.","journal-title":"Postep Dermatologii i Alergol"},{"issue":"8","key":"262_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/archdermatol.2009.78","volume":"145","author":"J Clark","year":"2009","unstructured":"Clark J, Yao L, Pavletic SZ, et al. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease. Arch Dermatol. 2009;145(8):918\u201322. https:\/\/doi.org\/10.1001\/archdermatol.2009.78.","journal-title":"Arch Dermatol"},{"issue":"6","key":"262_CR46","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbmt.2013.03.014","volume":"19","author":"J Pidala","year":"2013","unstructured":"Pidala J, Chai X, Martin P, et al. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the chronic GVHD consortium. Biol Blood Marrow Transpl. 2013;19(6):967\u201372. https:\/\/doi.org\/10.1016\/j.bbmt.2013.03.014.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"262_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pmr.2016.08.009","volume":"28","author":"SR Smith","year":"2017","unstructured":"Smith SR, Asher A. Rehabilitation in chronic graft-versus-host disease. Phys Med Rehabil Clin N Am. 2017;28(1):143\u201351. https:\/\/doi.org\/10.1016\/j.pmr.2016.08.009.","journal-title":"Phys Med Rehabil Clin N Am"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-022-00262-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-022-00262-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-022-00262-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T09:04:06Z","timestamp":1661245446000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-022-00262-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1186\/s42358-022-00262-3","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Salamanca University Hospital Drug Research Ethics Committee (code: 2020 10 586).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients or their guardians were informed and gave written consent in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}